KSHV INFLAMMATORY CYTOKINE SYNDROME (KICS)
Clinical trials for KSHV INFLAMMATORY CYTOKINE SYNDROME (KICS) explained in plain language.
Never miss a new study
Get alerted when new KSHV INFLAMMATORY CYTOKINE SYNDROME (KICS) trials appear
Sign up with your email to follow new studies for KSHV INFLAMMATORY CYTOKINE SYNDROME (KICS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets deadly inflammation in HIV patients
Disease control Recruiting nowThis study tests a drug called pacritinib in people with HIV who have two rare conditions caused by the Kaposi sarcoma herpesvirus (KSHV): KSHV-associated multicentric Castleman disease (MCD) and KSHV inflammatory cytokine syndrome (KICS). These conditions cause severe, life-thre…
Matched conditions: KSHV INFLAMMATORY CYTOKINE SYNDROME (KICS)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 12, 2026 12:06 UTC
-
New study sheds light on mysterious KSHV syndrome
Knowledge-focused Recruiting nowThis study aims to learn more about KSHV inflammatory cytokine syndrome (KICS), a newly recognized illness caused by a virus that can also lead to certain cancers. Researchers will collect medical history, blood samples, and imaging from 140 adults with KICS to understand how the…
Matched conditions: KSHV INFLAMMATORY CYTOKINE SYNDROME (KICS)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC